Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Open Access
- 31 August 2012
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 33 (23), 5776-5787
- https://doi.org/10.1016/j.biomaterials.2012.04.029
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell propertiesZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- PKC-θ function at the immunological synapse: prospects for therapeutic targetingTrends in Immunology, 2011
- Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterialsNano Today, 2011
- Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanismsBiomaterials, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010
- Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical TrialMolecular Therapy, 2010
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleasesNature Biotechnology, 2008
- Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availabilityProceedings of the National Academy of Sciences of the United States of America, 2007